Mucofan (BioDeep_00000615653)

   


代谢物信息卡片


2-Amino-3-[(carboxymethyl)sulfanyl]propanoic acid

化学式: C5H9NO4S (179.0252)
中文名称: 羧甲司坦
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C(C(C(=O)O)N)SCC(=O)O
InChI: InChI=1S/C5H9NO4S/c6-3(5(9)10)1-11-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表
Cytoplasm 9 ABL1, AKR1C3, ALB, DDO, DES, ELANE, NR5A2, PML, SRPX2
Peripheral membrane protein 1 PML
Endoplasmic reticulum membrane 1 PML
Nucleus 8 ABL1, AFF1, AKR1C3, ALB, DES, NR5A2, PML, TIMP3
cytosol 9 ABL1, AKR1C3, ALB, DDO, DES, ELANE, PAH, PML, TCHH
dendrite 1 ABL1
nuclear body 1 ABL1
phagocytic vesicle 1 ELANE
centrosome 1 ALB
nucleoplasm 3 ABL1, NR5A2, PML
RNA polymerase II transcription regulator complex 1 NR5A2
Cell membrane 1 PTAFR
Cytoplasmic side 1 PML
Early endosome membrane 1 PML
Multi-pass membrane protein 1 PTAFR
Synapse 1 SRPX2
cell surface 2 ELANE, SRPX2
glutamatergic synapse 3 ABL1, C1QL3, SRPX2
Golgi apparatus 2 ALB, SERPINA1
growth cone 1 ABL1
neuromuscular junction 1 DES
neuronal cell body 1 ABL1
postsynapse 1 ABL1
sarcolemma 1 DES
Cytoplasm, cytosol 1 DDO
plasma membrane 4 ABL1, IFNLR1, MUC5AC, PTAFR
Membrane 2 IFNLR1, PTAFR
extracellular exosome 7 AKR1C3, ALB, DES, ELANE, LYZ, MUC5AC, SERPINA1
endoplasmic reticulum 2 ALB, SERPINA1
extracellular space 8 ALB, ELANE, LYZ, MUC5AC, SERPINA1, SRPX2, TIMP3, XCL1
perinuclear region of cytoplasm 1 ABL1
intercalated disc 1 DES
mitochondrion 1 ABL1
protein-containing complex 2 ABL1, ALB
intracellular membrane-bounded organelle 1 SERPINA1
postsynaptic density 1 ABL1
Single-pass type I membrane protein 1 IFNLR1
Secreted 4 ALB, C1QL3, MUC5AC, SRPX2
extracellular region 7 ALB, ELANE, LYZ, MUC5AC, SERPINA1, TIMP3, XCL1
excitatory synapse 1 SRPX2
hippocampal mossy fiber to CA3 synapse 1 C1QL3
anchoring junction 1 ALB
nuclear membrane 2 ABL1, PML
actin cytoskeleton 1 ABL1
Z disc 1 DES
nucleolus 2 ABL1, PML
cell-cell junction 1 DES
COPII-coated ER to Golgi transport vesicle 1 SERPINA1
Cell membrane, sarcolemma 1 DES
extracellular matrix 2 MUC5AC, TIMP3
Peroxisome 1 DDO
basement membrane 1 TIMP3
collagen trimer 1 C1QL3
Peroxisome matrix 1 DDO
peroxisomal matrix 1 DDO
Nucleus, PML body 1 PML
PML body 1 PML
collagen-containing extracellular matrix 4 ELANE, SERPINA1, SRPX2, TIMP3
secretory granule 1 ELANE
fascia adherens 1 DES
intermediate filament 1 DES
ruffle 1 ABL1
ciliary basal body 1 ALB
chromatin 1 NR5A2
cytoskeleton 1 TCHH
centriole 1 ALB
spindle pole 1 ALB
chromosome, telomeric region 1 PML
blood microparticle 1 ALB
nuclear envelope 1 DES
Nucleus envelope 1 DES
Cornified envelope 1 TCHH
tertiary granule membrane 1 PTAFR
intermediate filament cytoskeleton 1 DES
Cytoplasm, myofibril, sarcomere, Z line 1 DES
synaptic membrane 1 SRPX2
ficolin-1-rich granule lumen 1 SERPINA1
secretory granule membrane 1 PTAFR
Golgi lumen 1 MUC5AC
endoplasmic reticulum lumen 2 ALB, SERPINA1
nuclear matrix 1 PML
transcription repressor complex 1 ELANE
platelet alpha granule lumen 2 ALB, SERPINA1
specific granule lumen 2 ELANE, LYZ
tertiary granule lumen 1 LYZ
transcription elongation factor complex 1 AFF1
azurophil granule lumen 2 ELANE, LYZ
Endoplasmic reticulum-Golgi intermediate compartment membrane 1 SERPINA1
cell tip 1 DES
synaptic cleft 1 C1QL3
Cytoplasmic vesicle, phagosome 1 ELANE
mucus layer 1 MUC5AC
cardiac myofibril 1 DES
platelet dense granule lumen 1 TIMP3
ciliary transition fiber 1 ALB
super elongation complex 1 AFF1
interleukin-28 receptor complex 1 IFNLR1
[Isoform DDO-1]: Peroxisome matrix 1 DDO
[Isoform 3]: Peroxisome matrix 1 DDO


文献列表

  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Yuko Higashi, Naoko Baba, Haruhito Yoshimine, Ikuyo Sakaguchi, Takuro Kanekura. Late-onset interstitial nephritis in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. The Journal of dermatology. 2020 Feb; 47(2):174-177. doi: 10.1111/1346-8138.15175. [PMID: 31840853]
  • Stephen C Mitchell, Glyn B Steventon. Phenylalanine 4-monooxygenase: the "sulfoxidation polymorphism". Xenobiotica; the fate of foreign compounds in biological systems. 2020 Jan; 50(1):51-63. doi: 10.1080/00498254.2019.1636419. [PMID: 31233370]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Kang Wu, Xiaofen Su, Guihua Li, Nuofu Zhang. Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnea Syndrome: A Randomized Clinical Trial. PloS one. 2016; 11(2):e0148519. doi: 10.1371/journal.pone.0148519. [PMID: 26849119]
  • Panayotis Panagopoulos, Stephen C Mitchell, Glyn B Steventon. S-carboxymethyl-L-cysteine and it (R/S)-S-oxides in beagle dog plasma and hepatic cytosol. Xenobiotica; the fate of foreign compounds in biological systems. 2015; 45(12):1047-53. doi: 10.3109/00498254.2015.1042538. [PMID: 26068525]
  • Elisabetta Pace, Maria Ferraro, Serena Di Vincenzo, Chiara Cipollina, Stefania Gerbino, Diego Cigna, Valentina Caputo, Rossella Balsamo, Luigi Lanata, Mark Gjomarkaj. Comparative cytoprotective effects of carbocysteine and fluticasone propionate in cigarette smoke extract-stimulated bronchial epithelial cells. Cell stress & chaperones. 2013 Nov; 18(6):733-43. doi: 10.1007/s12192-013-0424-0. [PMID: 23580157]
  • Olumuyiwa S Falade, Steve R A Adewusi, Chris E Harwood. S-Carboxyethylcysteine (a constituent of Acacia seed) negatively affects casein protein utilization by rats. Nutrition (Burbank, Los Angeles County, Calif.). 2012 Jul; 28(7-8):785-92. doi: 10.1016/j.nut.2011.10.004. [PMID: 22209464]
  • Glyn B Steventon, Stephen C Mitchell, Santigo Angulo, Coral Barbas. An investigation into possible xenobiotic-endobiotic inter-relationships involving the amino acid analogue drug, S-carboxymethyl-L-cysteine and plasma amino acids in humans. Amino acids. 2012 May; 42(5):1967-73. doi: 10.1007/s00726-011-0926-y. [PMID: 21559953]
  • Fei Li, Andrew D Patterson, Constance C Höfer, Kristopher W Krausz, Frank J Gonzalez, Jeffrey R Idle. A comprehensive understanding of thioTEPA metabolism in the mouse using UPLC-ESI-QTOFMS-based metabolomics. Biochemical pharmacology. 2011 Apr; 81(8):1043-53. doi: 10.1016/j.bcp.2011.01.024. [PMID: 21300029]
  • Ahmed A Mostafa, Edward W Randell, Sudesh C Vasdev, Vicki D Gill, Yingchun Han, Vereesh Gadag, Ahmed A Raouf, Hala El Said. Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes. Molecular and cellular biochemistry. 2007 Aug; 302(1-2):35-42. doi: 10.1007/s11010-007-9422-9. [PMID: 17318407]
  • Jing Zhu, Xin Zhou, Hu Zheng, Zhangwan Li. Enantioselective determination of dencichine in rabbit plasma by high-performance liquid chromatography-electrospray mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2006 Aug; 840(2):124-31. doi: 10.1016/j.jchromb.2006.04.041. [PMID: 16730243]
  • D Jovanović, S Cusić, Z Segrt, D Dordević, M Vehabović, N Potogija. A comparative bioavailability study of a generic capsule formulation containing carbocysteine. Die Pharmazie. 2006 May; 61(5):446-9. doi: NULL. [PMID: 16724543]
  • Hui-Chang Bi, Li-zi Zhao, Guo-ping Zhong, Shufeng Zhou, Bo Li, Ying Deng, Xiao Chen, Min Huang. High-throughput determination of carbocysteine in human plasma by liquid chromatography/tandem mass spectrometry: application to a bioequivalence study of two formulations in healthy volunteers. Rapid communications in mass spectrometry : RCM. 2006; 20(7):1153-60. doi: 10.1002/rcm.2422. [PMID: 16521164]
  • Peter J Bull, Richard K Brooke, John Cocker, Katharine Jones, Nicholas Warren. An occupational hygiene investigation of exposure to acrylamide and the role for urinary S-carboxyethyl-cysteine (CEC) as a biological marker. The Annals of occupational hygiene. 2005 Nov; 49(8):683-90. doi: 10.1093/annhyg/mei028. [PMID: 16141254]
  • Jingmin Zeng, Michael J Davies. Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins. Chemical research in toxicology. 2005 Aug; 18(8):1232-41. doi: 10.1021/tx050074u. [PMID: 16097796]
  • Boontarika Boonyapiwat, Ben Forbes, Glyn B Steventon. Phenylalanine hydroxylase: possible involvement in the S-oxidation of S-carboxymethyl-l-cysteine. Analytical biochemistry. 2004 Dec; 335(1):91-7. doi: 10.1016/j.ab.2004.08.003. [PMID: 15519575]
  • Yu-hong Li, Xin Zhao, Qing Ji, Jian-guo Xu, Rui-yuan Sun. A nomogram for prediction of absorption rate coefficient. Chinese medical journal. 2004 May; 117(5):689-94. doi: NULL. [PMID: 15161535]
  • E S Roopnarinsingh, G B Steventon, R M Harris, R H Waring, S C Mitchell. The effect of cysteine analogues on the excretion of urinary sulphate in the rat following cysteine administration. Drug metabolism and drug interactions. 2004; 20(1-2):1-10. doi: 10.1515/dmdi.2004.20.1-2.1. [PMID: 15283299]
  • M I Walash, M E-S Metwally, A M El-Brashy, A A Abdelal. Kinetic spectrophotometric determination of some sulfur containing compounds in pharmaceutical preparations and human serum. Farmaco (Societa chimica italiana : 1989). 2003 Dec; 58(12):1325-32. doi: 10.1016/s0014-827x(03)00167-8. [PMID: 14630247]
  • Nelly Lugo-Vallín, Idania Maradei-Irastorza, Carmine Pascuzzo-Lima, Manuel Ramírez-Sánchez, Claudia Montesinos. Thirty-five cases of S-carboxymethylcysteine use in paraquat poisoning. Veterinary and human toxicology. 2003 Feb; 45(1):45-6. doi: . [PMID: 12583701]
  • Laura Brandolini, Marcello Allegretti, Valerio Berdini, Maria Neve Cervellera, Patrizia Mascagni, Matteo Rinaldi, Gabriella Melillo, Pietro Ghezzi, Manuela Mengozzi, Riccardo Bertini. Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROIs). European cytokine network. 2003 Jan; 14(1):20-6. doi: . [PMID: 12799210]
  • R H Waring, R M Harris, G B Steventon, S C Mitchell. Degradation to sulphate of S-methyl-L-cysteine sulphoxide and S-carboxymethyl-L-cysteine sulphoxide in man. Drug metabolism and drug interactions. 2003; 19(4):241-55. doi: 10.1515/dmdi.2003.19.4.241. [PMID: 14768973]
  • Glyn B Steventon, Rosemary H Waring, Adrian C Williams. An investigation into the inter-relationships of sulphur xeno-biotransformation pathways in Parkinson's and motor neurone diseases. Drug metabolism and drug interactions. 2003; 19(4):223-40. doi: 10.1515/dmdi.2003.19.4.223. [PMID: 14768972]
  • P Nicolao, B Giometto. Neurological toxicity of ifosfamide. Oncology. 2003; 65 Suppl 2(?):11-6. doi: 10.1159/000073352. [PMID: 14586141]
  • Xiaoyan Chen, Dafang Zhong, Ying Han, Zhiyong Xie. Determination of carbocysteine in human plasma by liquid chromatography/tandem mass spectrometry employing precolumn derivatization. Rapid communications in mass spectrometry : RCM. 2003; 17(3):192-6. doi: 10.1002/rcm.894. [PMID: 12539182]
  • S Pinamonti, L Venturoli, M Leis, M Chicca, A Barbieri, S Sostero, F Ravenna, L Daffonchio, R Novellini, A Ciaccia. Antioxidant activity of carbocysteine lysine salt monohydrate. Panminerva medica. 2001 Sep; 43(3):215-20. doi: NULL. [PMID: 11579333]
  • G B Steventon. Diurnal variation in the metabolism of S-carboxymethyl-L-cysteine in humans. Drug metabolism and disposition: the biological fate of chemicals. 1999 Sep; 27(9):1092-7. doi: NULL. [PMID: 10460812]
  • R Anacardio, M G Cantalini, F De Angelis, M Gentile. Quantification of S-carboxymethyl-(R)-cysteine in human plasma by high-performance ion-exchange liquid chromatography/atmospheric pressure ionization mass spectrometry. Journal of mass spectrometry : JMS. 1997 Apr; 32(4):388-94. doi: 10.1002/(sici)1096-9888(199704)32:4<388::aid-jms462>3.0.co;2-8. [PMID: 9130397]
  • D Gainey, S Short, K L McCoy. Intracellular location of cysteine transport activity correlates with productive processing of antigen disulfide. Journal of cellular physiology. 1996 Aug; 168(2):248-54. doi: 10.1002/(sici)1097-4652(199608)168:2<248::aid-jcp3>3.0.co;2-p. [PMID: 8707860]
  • I Değirmenci, A Başaran, K Erol, E Açikalin, H V Günes, S Yazictoğlu, A G Tomatír, H Gün. Effects of S-CMC on the cisplatin toxicity in rats. Urologia internationalis. 1996; 57(2):99-103. doi: 10.1159/000282888. [PMID: 8873366]
  • M H Davies, J M Ngong, A Pean, C R Vickers, R H Waring, E Elias. Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis. Journal of hepatology. 1995 May; 22(5):551-60. doi: 10.1016/0168-8278(95)80450-1. [PMID: 7650336]
  • H Iwase, S Ozawa, M Ikuta, I Ono. Determination of amino acids in human plasma by liquid chromatography with postcolumn ninhydrin derivatization using a hydroxyapatite cartridge for precolumn deproteination. Journal of chromatography. B, Biomedical applications. 1995 Jan; 663(1):15-24. doi: 10.1016/0378-4347(94)00439-c. [PMID: 7704203]
  • S Futani, T Ubuka, T Abe. High-performance liquid chromatographic determination of hypotaurine and taurine after conversion to 4-dimethylaminoazobenzene-4'-sulfonyl derivatives and its application to the urine of cysteine-administered rats. Journal of chromatography. B, Biomedical applications. 1994 Oct; 660(1):164-9. doi: 10.1016/0378-4347(94)00280-0. [PMID: 7858709]
  • W L Gregory, O F James, I Turner, C O Meese, J R Idle. Re-evaluation of the metabolism of carbocisteine in a British white population. Pharmacogenetics. 1993 Oct; 3(5):270-4. doi: 10.1097/00008571-199310000-00007. [PMID: 8287066]
  • R H Waring, P Emery. Management of early inflammatory arthritis. Genetic factors predicting persistent disease: the role of defective enzyme systems. Bailliere's clinical rheumatology. 1992 Jun; 6(2):337-50. doi: 10.1016/s0950-3579(05)80178-5. [PMID: 1525843]
  • W L Gregory, O F James, J R Idle. Carbocisteine polymorphism and disease. Lancet (London, England). 1992 Mar; 339(8793):616-7. doi: 10.1016/0140-6736(92)90902-f. [PMID: 1347115]
  • C Gordon, H Bradley, R H Waring, P Emery. Abnormal sulphur oxidation in systemic lupus erythematosus. Lancet (London, England). 1992 Jan; 339(8784):25-6. doi: 10.1016/0140-6736(92)90144-r. [PMID: 1345954]
  • B Staffeldt, J Brockmöller, I Roots. Determination of S-carboxymethyl-L-cysteine and some of its metabolites in urine and serum by high-performance liquid chromatography using fluorescent pre-column labelling. Journal of chromatography. 1991 Nov; 571(1-2):133-47. doi: 10.1016/0378-4347(91)80440-n. [PMID: 1810942]
  • C O Meese, C Fischer, A Küpfer, H Wisser, M Eichelbaum. Identification of the 'major' polymorphic carbocysteine metabolite as S-(carboxymethylthio)-L-cysteine. Biochemical pharmacology. 1991 Oct; 42(10):R13-6. doi: 10.1016/0006-2952(91)90579-t. [PMID: 1741762]
  • A D MBewu, P N Durrington, D Bhatnagar, J P Miller, M I Mackness. Oral carbocisteine does not lower serum lipoprotein(a) levels. Atherosclerosis. 1991 Oct; 90(2-3):219-20. doi: 10.1016/0021-9150(91)90118-m. [PMID: 1836948]
  • J Brockmöller, B Staffeldt, I Roots. Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification. European journal of clinical pharmacology. 1991; 40(4):387-92. doi: 10.1007/bf00265849. [PMID: 2050173]
  • U Hofmann, M Eichelbaum, S Seefried, C O Meese. Identification of thiodiglycolic acid, thiodiglycolic acid sulfoxide, and (3-carboxymethylthio)lactic acid as major human biotransformation products of S-carboxymethyl-L-cysteine. Drug metabolism and disposition: the biological fate of chemicals. 1991 Jan; 19(1):222-6. doi: . [PMID: 1673403]
  • A Williams, S Sturman, G Steventon, R Waring. Metabolic biomarkers of Parkinson's disease. Acta neurologica Scandinavica. Supplementum. 1991; 136(?):19-23. doi: 10.1111/j.1600-0404.1991.tb05015.x. [PMID: 1801532]
  • C O Meese, P Fischer. Tracing the human metabolism of stable isotope-labelled drugs by ex vivo NMR spectroscopy. A revision of S-carboxymethyl-L-cysteine biotransformation. Zeitschrift fur Naturforschung. C, Journal of biosciences. 1990 Nov; 45(11-12):1171-5. doi: 10.1515/znc-1990-11-1215. [PMID: 2095787]
  • Y Tanaka, W Thormann. Capillary electrophoretic determination of S-carboxymethyl-L-cysteine and its major metabolites in human urine: feasibility investigation using on-column detection of non-derivatized solutes in capillaries with minimal electroosmosis. Electrophoresis. 1990 Sep; 11(9):760-4. doi: 10.1002/elps.1150110914. [PMID: 2257847]
  • R H Waring, S C Mitchell. Carbocisteine sulphoxidation phenotype. Lancet (London, England). 1990 Jun; 335(8704):1527. doi: 10.1016/0140-6736(90)93064-v. [PMID: 1972452]
  • N Kolodny, F A Robey. Conjugation of synthetic peptides to proteins: quantitation from S-carboxymethylcysteine released upon acid hydrolysis. Analytical biochemistry. 1990 May; 187(1):136-40. doi: 10.1016/0003-2697(90)90431-8. [PMID: 2372110]
  • A Küpfer, J R Idle. False positives with current carbocisteine protocol for sulphoxidation phenotyping. Lancet (London, England). 1990 May; 335(8697):1107. doi: 10.1016/0140-6736(90)92688-e. [PMID: 1970413]
  • Y Majima, K Takeuchi, Y Sakakura. Effects of myringotomy and orally administered drugs on viscosity and elasticity of middle ear effusions from children with otitis media with effusion. Acta oto-laryngologica. Supplementum. 1990; 471(?):66-72. doi: 10.3109/00016489009124812. [PMID: 2239251]
  • V Brumas, M Venturini, M Filella, G Berthon. Quantitative investigation of copper(II) and zinc(II) complexes with S-carboxymethyl-L-cysteine and computer-simulated appraisal of their potential significance in vivo. Journal of inorganic biochemistry. 1989 Dec; 37(4):309-23. doi: 10.1016/0162-0134(89)85005-6. [PMID: 2628548]
  • D F Rogers, N C Turner, C Marriott, P K Jeffery. Oral N-acetylcysteine or S-carboxymethylcysteine inhibit cigarette smoke-induced hypersecretion of mucus in rat larynx and trachea in situ. The European respiratory journal. 1989 Nov; 2(10):955-60. doi: . [PMID: 2532606]
  • G Gillon, A R Mundy. The dissolution of urinary mucus after cystoplasty. British journal of urology. 1989 Apr; 63(4):372-4. doi: 10.1111/j.1464-410x.1989.tb05220.x. [PMID: 2713619]
  • E F Karim, J S Millership, D J Temple, A D Woolfson. An investigation of the metabolism of S-carboxymethyl-L-cysteine in man using a novel HPLC-ECD method. European journal of drug metabolism and pharmacokinetics. 1988 Oct; 13(4):253-6. doi: 10.1007/bf03190087. [PMID: 3243319]
  • P Decottignies, J M Schmitter, M Miginiac-Maslow, P Le Maréchal, J P Jacquot, P Gadal. Primary structure of the light-dependent regulatory site of corn NADP-malate dehydrogenase. The Journal of biological chemistry. 1988 Aug; 263(24):11780-5. doi: 10.1016/s0021-9258(18)37852-9. [PMID: 3403553]
  • R G Watson, A Olomu, D Clements, R H Waring, S Mitchell, E Elias. A proposed mechanism for chlorpromazine jaundice--defective hepatic sulphoxidation combined with rapid hydroxylation. Journal of hepatology. 1988 Aug; 7(1):72-8. doi: 10.1016/s0168-8278(88)80508-7. [PMID: 3183354]
  • J A De Schutter, G Van der Weken, W Van den Bossche, P de Moerloose. Determination of S-carboxymethylcysteine in serum by reversed-phase ion-pair liquid chromatography with column switching following pre-column derivatization with o-phthalaldehyde. Journal of chromatography. 1988 Jul; 428(2):301-10. doi: 10.1016/s0378-4347(00)83921-3. [PMID: 3215933]
  • G K Scadding, R Ayesh, J Brostoff, S C Mitchell, R H Waring, R L Smith. Poor sulphoxidation ability in patients with food sensitivity. BMJ (Clinical research ed.). 1988 Jul; 297(6641):105-7. doi: 10.1136/bmj.297.6641.105. [PMID: 3408928]
  • J Bron. Relative bioavailability of carbocysteine from three dosage forms, investigated in healthy volunteers. Biopharmaceutics & drug disposition. 1988 Jan; 9(1):97-111. doi: 10.1002/bod.2510090110. [PMID: 3342289]
  • J F Desaga. [Use of mucolytic agents and guaran Hepart (HP-7000) for imaging mucosal villi in double-contrast studies of the small intestine]. Rontgen-Blatter; Zeitschrift fur Rontgen-Technik und medizinisch-wissenschaftliche Photographie. 1987 Dec; 40(12):398-400. doi: ". [PMID: 3445095]
  • C Dubruc, P Hermann, A Haddouche, M M Badarani, J P Thénot. Determination of S-carboxymethyl-L-cysteine in plasma by high-performance liquid chromatography with column switching following precolumn derivatization. Journal of chromatography. 1987 Jun; 417(1):208-15. doi: 10.1016/0378-4347(87)80110-x. [PMID: 3624399]
  • J Bron. High pressure liquid chromatographic determination of carbocisteine in human plasma and urine. Pharmaceutisch weekblad. Scientific edition. 1986 Apr; 8(2):134-8. doi: 10.1007/bf02086147. [PMID: 3086832]
  • P C Braga, F Scaglione, G Scarpazza, G Fraticelli, G Roviaro, F Varoli, C Mariani, M Falchi, F Fraschini. Comparison between penetration of amoxicillin combined with carbocysteine and amoxicillin alone in pathological bronchial secretions and pulmonary tissue. International journal of clinical pharmacology research. 1985; 5(5):331-40. doi: . [PMID: 4066083]
  • D Lutz, W Gielsdorf, J Rasper, H Jaeger, M Albring, G Eisler, G Niebch. [The bioavailability and pharmacokinetics of two carbocysteine preparations after single and multiple dosing]. Arzneimittel-Forschung. 1985; 35(1):163-6. doi: NULL. [PMID: 4039146]
  • S C Mitchell, R H Waring, C S Haley, J R Idle, R L Smith. Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man. British journal of clinical pharmacology. 1984 Oct; 18(4):507-21. doi: 10.1111/j.1365-2125.1984.tb02498.x. [PMID: 6487492]
  • C Ioannides, D E Hall, D E Mulder, C M Steele, J Spickett, M Delaforge, D V Parke. A comparison of the protective effects of N-acetyl-cysteine and S-carboxymethylcysteine against paracetamol-induced hepatotoxicity. Toxicology. 1983 Nov; 28(4):313-21. doi: 10.1016/0300-483x(83)90005-7. [PMID: 6648979]
  • R H Waring, S C Mitchell, R R Shah. The metabolism of S-carboxymethyl-L-cysteine in man: isolation of an ester glucuronic acid conjugate from urine. Xenobiotica; the fate of foreign compounds in biological systems. 1983 May; 13(5):311-7. doi: 10.3109/00498258309052269. [PMID: 6636828]
  • R H Waring, S C Mitchell, R R Shah, J R Idle, R L Smith. Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in man. Biochemical pharmacology. 1982 Oct; 31(19):3151-4. doi: 10.1016/0006-2952(82)90102-2. [PMID: 7150344]
  • J M Aiache, J P Borel, J P Kantelip. Comparative bioavailability of S-carboxymethylcysteine from two dosage forms: hard gelatin capsule and syrup. Biopharmaceutics & drug disposition. 1982 Jul; 3(3):275-81. doi: 10.1002/bdd.2510030310. [PMID: 7139067]
  • E Gaetani, C F Laureri, M Vitto, F Bordi. [Determination of S-carboxymethylcysteine in plasma by HPLC and fluorimetric detection]. Il Farmaco; edizione pratica. 1982 Jul; 37(7):235-8. doi: NULL. [PMID: 7128774]
  • E Concia, C Dos Santos, P Marone, C Sardi, P Cremaschi. [Serum and bronchial concentrations of amoxicillin administered with a bronchial fluidizer]. Bollettino dell'Istituto sieroterapico milanese. 1982 Mar; 61(1):64-70. doi: NULL. [PMID: 7126331]
  • D Godeneche, M F Moreau, J C Madelmont, J Duprat, R Plagne. Disposition and metabolism in 1-(2-chloroethyl)-3-(2',3',4'-tri-o-acetyl, ribopyranosyl)-1-nitrosourea in rats. Cancer research. 1982 Feb; 42(2):525-9. doi: . [PMID: 6799188]
  • R H Waring, S C Mitchell. The metabolism and elimination of S-carboxymethyl-L-cysteine in man. Drug metabolism and disposition: the biological fate of chemicals. 1982 Jan; 10(1):61-2. doi: NULL. [PMID: 6124385]
  • P C Braga, M Borsa, L De Angelis, R Bossi, L Allegra, F Scaglione, G Scarpazza. Pharmacokinetic behavior of S-carboxymethylcysteine-Lys in patients with chronic bronchitis. Clinical therapeutics. 1982; 4(6):480-8. doi: NULL. [PMID: 7093981]
  • R H Waring. Variation in human metabolism of S-carboxymethylcysteine. European journal of drug metabolism and pharmacokinetics. 1980; 5(1):49-52. doi: 10.1007/bf03189444. [PMID: 7389752]
  • G Müller, K Norpoth, R Eckard. Identification of S-(carboxymethyl)-L-cysteine and thiodiglycolic acid, urinary metabolites of 2,2'-bis-(chloroethyl)-ether in the rat. Cancer letters. 1979 Sep; 7(5):299-305. doi: 10.1016/s0304-3835(79)80057-9. [PMID: 509409]
  • D Reichert, H W Werner, M Metzler, D Henschler. Molecular mechanism of 1,1-dichloroethylene toxicity: excreted metabolites reveal different pathways of reactive intermediates. Archives of toxicology. 1979 Jul; 42(3):159-69. doi: 10.1007/bf00353707. [PMID: 475590]
  • E Dolfini, R Testa. Gas liquid chromatographic determination of S-carboxymethylcysteine in human urine. Il Farmaco; edizione pratica. 1979 Mar; 34(3):114-20. doi: NULL. [PMID: 456545]
  • R J Mead, A J Oliver, D R King. Metabolism and defluorination of fluoroacetate in the brush-tailed possum (Trichosurus vulpecula). Australian journal of biological sciences. 1979 Feb; 32(1):15-26. doi: . [PMID: 485974]
  • A N Glazer, C S Hixson, R J DeLange. Determination of the number of thioether-linked cysteine residues in cytochromes c and phycobiliproteins. Analytical biochemistry. 1979 Jan; 92(2):489-96. doi: 10.1016/0003-2697(79)90689-4. [PMID: 220892]
  • W R Maynard, R B Bruce, G G Fox. Determination of carbocysteine from human plasma. Journal of pharmaceutical sciences. 1978 Dec; 67(12):1753-5. doi: 10.1002/jps.2600671232. [PMID: 722496]
  • E Puchelle, F Aug, J M Polu. Effect of the mucoregulator S-carboxy-methyl-cysteine in patients with chronic bronchitis. European journal of clinical pharmacology. 1978 Nov; 14(3):177-84. doi: 10.1007/bf02089957. [PMID: 365537]
  • L B Turnbull, L Teng, J M Kinzie, J E Pitts, F M Pinchbeck, R B Bruce. Excretion and biotransformation of carboxymethyl-cysteine in rat, dog, monkey and man. Xenobiotica; the fate of foreign compounds in biological systems. 1978 Oct; 8(10):621-8. doi: 10.3109/00498257809069574. [PMID: 102086]
  • R H Waring. The metabolism of S-carboxymethylcysteine in rodents, marmosets and humans. Xenobiotica; the fate of foreign compounds in biological systems. 1978 May; 8(5):265-70. doi: 10.3109/00498257809060949. [PMID: 96615]
  • B K Jones, D E Hathway. Differences in metabolism of vinylidene chloride between mice and rats. British journal of cancer. 1978 Mar; 37(3):411-7. doi: 10.1038/bjc.1978.61. [PMID: 638019]
  • A Rinaldi, M B Fadda, C De Marco. Oxidative deamination of carboxyethyl-cysteine and carboxymethyl-homocysteine. Physiological chemistry and physics. 1978; 10(1):47-57. doi: NULL. [PMID: 724799]
  • K M Rogers, E A Barnsley. The metabolism of S-carboxyalkylcysteines in man. Xenobiotica; the fate of foreign compounds in biological systems. 1977 Jul; 7(7):409-14. doi: 10.3109/00498257709035800. [PMID: 888445]
  • G Müller, K Norpoth, R Eckard. Identification of two urine metabolites of vinyl chloride by GC-MS-investigations. International archives of occupational and environmental health. 1976 Oct; 38(1):69-75. doi: 10.1007/bf00378322. [PMID: 977153]
  • G Müller, K Norpoth. [Determination of 2 vinylchloride metabolites in urine]. Die Naturwissenschaften. 1975 Nov; 62(11):541. doi: 10.1007/bf00609083. [PMID: 1214857]
  • D J Reed, H E May. Alkylation and carbamoylation intermediates from the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)-1. Life sciences. 1975 Apr; 16(8):1263-70. doi: 10.1016/0024-3205(75)90311-2. [PMID: 1134193]